Galantamine ameliorates experimental pancreatitis.

Dane A ThompsonTea TsaavaArvind RishiSam J GeorgeTyler D HeplerDaniel HydeValentin A PavlovMichael BrinesSangeeta S ChavanKevin J Tracey

Published in: Molecular medicine (Cambridge, Mass.) (2023)

Galantamine improves acute pancreatitis via a mechanism which does not involve previously established physiological and molecular components of the CAP. As galantamine is an approved drug in widespread clinical use with an excellent safety record, our findings are of interest for further evaluating the potential benefits of this drug in patients with acute pancreatitis.

Keyphrases

adverse drug
drug induced
mouse model
emergency department
risk assessment
human health
single molecule